Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients.

导出 OA

翻译打印收藏纠错

第一作者： Florence,Duffaud

第一单位： Centre Léon Bérard, Department of Medecine, French Sarcoma Group (GSF-GETO), European Organisation for Research and Treatment of Cancer (EORTC), University Claude Bernard Lyon I, Lyon, France. jean-yves.blay@lyon.unicancer.fr.

作者： Florence,Duffaud ^[1] ; Caroline,Even ; Isabelle,Ray-Coquard ; Emmanuelle,Bompas ; Thanh,Khoa-Huynh ; Sebastien,Salas ; Philippe,Cassier ; Armelle,Dufresne ; Sylvie,Bonvalot ; Francoise,Ducimetiere ; Axel,Le Cesne ; Jean-Yves,Blay

作者单位： Centre Léon Bérard, Department of Medecine, French Sarcoma Group (GSF-GETO), European Organisation for Research and Treatment of Cancer (EORTC), University Claude Bernard Lyon I, Lyon, France. jean-yves.blay@lyon.unicancer.fr. ^[1]

DOI 10.1186/2045-3329-2-11

PMID 22950685

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览10

Clinical sarcoma research

2012年2卷1期

11页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients.

Clinical sarcoma research

相似文献

Clinical sarcoma research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients.

Clinical sarcoma research

相似文献

Clinical sarcoma research

相关期刊

检索历史清除